{"id":"W4311456903","doi":"10.1016/j.jacadv.2022.100148","title":"Improvements in Efficacy Measures With Tafamidis in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial","year":2022,"lang":"en","type":"article","venue":"JACC Advances","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Janssen Biotech; Pfizer UK; Pfizer","keywords":"Medicine; Placebo; Confidence interval; Odds ratio; Internal medicine; Clinical trial; Randomized controlled trial; Cardiomyopathy; Transthyretin; Physical therapy; Heart failure; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002626094,0.0006625724,0.001849849,0.0002114928,0.0002850884,0.0006663977,0.0003554778,0.001121061,0.004585616],"category_scores_gemma":[0.002480393,0.0002049182,0.001439841,0.0002588363,0.0003671038,0.0004615797,0.0002673268,0.001847387,0.0004485678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004336701,"about_ca_system_score_gemma":0.0007388798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004357907,"about_ca_topic_score_gemma":0.001121546,"domain_scores_codex":[0.9990382,0.0005796772,0.00007140599,0.0001128707,0.00008360986,0.0001141436],"domain_scores_gemma":[0.998463,0.0005840989,0.0003918215,0.00007074465,0.0001326892,0.000357571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9668872,0.002099461,0.005065942,0.0005872845,0.001623184,0.00006328338,0.00005210669,0.0004497833,0.002925323,0.0001007472,0.001648317,0.01849728],"study_design_scores_gemma":[0.8417421,0.1018614,0.04900403,0.0001271904,0.002495762,0.0001779992,0.00003954733,0.001122893,0.00117708,0.0002816836,0.001942063,0.00002816462],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906318,0.003850046,0.0002322998,0.0006833256,0.0001130045,0.0008603446,0.001387309,0.00004355798,0.002198253],"genre_scores_gemma":[0.9941071,0.001106618,0.0004362356,0.0004180097,0.0001722229,0.001112774,0.001267104,0.000007199412,0.00137283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004585616,"threshold_uncertainty_score":0.01534045,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02641622557964836,"score_gpt":0.3325781476394969,"score_spread":0.3061619220598485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}